Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia · Delayed Price · Currency is SAR 87.25
+0.65 (0.75%)
Oct 15, 2026, 3:15 PM AST
Nahdi Medical Company Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Nahdi Medical Company stock has a consensus rating of "Buy" and an average price target of SAR 115.52. The average 1-year stock price forecast is 32.40% higher than the current stock price, while the lowest is SAR 100.00 (+14.61%) and the highest is SAR 142.00 (+62.75%).
Price Target: SAR 115.52 (+32.40%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nahdi Medical Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 3 | 3 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Financial Forecast
Revenue This Year
10.87B
from 10.21B
Increased by 6.43%
Revenue Next Year
11.65B
from 10.87B
Increased by 7.19%
EPS This Year
6.24
from 6.39
Decreased by -2.38%
EPS Next Year
6.64
from 6.24
Increased by 6.43%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.